H.I.V. Research Networks Confront Uncertainty Due to Funding Delays

H.I.V. research networks, which also contribute to treatments and preventions for other infectious diseases and played a key role in testing the Covid vaccine, are facing an uncertain future amid delays in funding. This situation raises concerns about the continuation of their critical work in infectious disease research and public health.

Originally published by nyt